Research institute in
Basel

PreClinical Safety (PCS) Consultants Ltd

Since 1996 · 1–10 empl.

PreClinical Safety (PCS) Consultants Ltd provides independent advisory services and pharmacological and non-clinical safety evaluations for the pharmaceutical, agrochemical, chemical and food industries. Its services include toxicology, drug development, quality assurance and regulatory documentation.

Denkstatt Sàrl

Since 1996 · 21–50 empl.

Denkstatt Sàrl is an interdisciplinary team working on transformative urban development and urban development cooperation. Its activities include area development and adaptive reuse, public-space and urban-climate strategies, participatory processes, and organizational development.

Elanco Tiergesundheit AG

Since 1997 · 21–50 empl.

The core activity of Elanco is the development and manufacture of animal health medicines and products that improve the health, well-being and performance of animals, as well as providing services and solutions for animal health.

Medpace Switzerland AG

Since 1998 · 11–20 empl.

Medpace Switzerland AG is a contract research organization (CRO) that provides services for clinical development of medical therapeutics. The company supports sponsors with study planning, clinical trial management, regulatory services, data management, and laboratory and imaging services.

Paul Schatz Stiftung zur Förderung von Zukunftstechnologien

Since 2000 · 1–10 empl.·3.7(3)

Paul Schatz Stiftung zur Förderung von Zukunftstechnologien preserves Paul Schatz’s scientific, artistic and educational legacy and makes it accessible to the public. It promotes future technologies, particularly developments involving Oloid technology, and presents Schatz’s work through exhibitions, events and workshops.

McArthur and Associates GmbH

Since 2001 · 11–20 empl.

McArthur and Associates GmbH advises the biopharmaceutical industry, venture capital organizations and academic groups on drug discovery and early clinical development. Its services include project evaluation, pharmacological studies, toxicology and biomarkers, and scientific communication.

Life Imaging Services GmbH

Since 2007 · 1–10 empl.

Life Imaging Services GmbH develops and manufactures tailored equipment and solutions for live microscopy. Its products include complete workstations, incubation and biosafety systems, microscope accessories, and software for image acquisition, processing and analysis.

Edelweiss Connect GmbH

Since 2008 · 11–20 empl.

The core activity of Edelweiss Connect is to provide services in the field of risk management and data management, particularly in the pharmaceutical industry and related areas. This includes, among other things: document management and analysis, risk assessment and management, research and development in collaboration with industry companies, academic institutions and regulatory authorities, and the development of solutions for complex business problems through the use of expert knowledge and collaborative approaches. The company focuses on providing innovative solutions and services to support the decision-making and success of its customers.

BioVersys AG

Since 2008 · 21–50 empl.

BioVersys AG is a pharmaceutical company researching and developing medicines for bacterial infections and antimicrobial resistance. It focuses on small molecules with novel modes of action, with development programs that include candidates for resistant hospital infections and tuberculosis.

PAREXEL International (CH) AG

Since 2008 · 1–10 empl.

PAREXEL International (CH) AG is a clinical research organization (CRO) that provides services for pharmaceutical and biopharmaceutical clinical development. Services include Phase I–IV clinical trial management, regulatory strategy and submissions, drug safety and pharmacovigilance, real‑world evidence and market access support, as well as clinical trial supply and medical communications.

SFL Regulatory Affairs & Scientific Communication GmbH

Since 2009 · 21–50 empl.

SFL Regulatory Affairs & Scientific Communication GmbH is part of Veristat and supports clinical development and regulatory work across the product lifecycle. Its services include program design, clinical trial execution, and support for therapy commercialization.

St. Clara Forschung AG

Since 2010 · 21–50 empl.

St. Clara Forschung AG conducts academic, non-commercial clinical and translational research in medicine and closely related fields. Its main areas include cancer research, metabolic and gastroenterological research, and visceral surgical research.

FGen AG

Since 2011 · 11–20 empl.

The core activity of Ginkgo Bioworks is the development and provision of research and development (R&D) solutions for various industries, including agriculture, biopharmaceuticals, biosecurity, government, and industrial biotechnology. The company offers a platform with various tools and services, including artificial intelligence (AI), laboratory automation, data analysis and generation, to accelerate customers' research and development. Ginkgo Bioworks works closely with its partners to develop customized R&D solutions and offer products and services tailored to the specific needs of its customers.

Ironwood Pharmaceuticals GmbH

Since 2012 · 21–50 empl.

Ironwood Pharmaceuticals GmbH is a biopharmaceutical company focused on gastrointestinal diseases. Its activities include developing and commercializing medicines such as linaclotide and evaluating apraglutide as an investigational drug in clinical trials.

NBE-Therapeutics AG

Since 2012 · 21–50 empl.

The core activity of NBE-Therapeutics AG is the development and research of therapeutics, particularly in the field of cancer treatment. The company focuses on the development of antibody-drug conjugates (ADCs) and other therapeutics targeting the fight against cancer cells.

Indivi AG

Since 2012 · 51–100 empl.

Indivi AG develops digital measurement tools for neuroscience clinical trials. Its platform combines smartphone-based motor and cognitive assessments with data analysis and supports the design, conduct, and analysis of early-phase studies.

MentAge GmbH

Since 2013 · 1–10 empl.

MentAge GmbH provides consulting, supervision and courses, as well as clinical services in the fields of dementia and geriatric medicine. The website also refers to expert reports, support for care facilities and dementia-friendly hospital concepts.

Amyra Biotech AG

Since 2013 · 1–10 empl.

Amyra Biotech AG develops solutions to supplement digestive enzyme activity in the small intestine. Its development pipeline includes consumer health products and prescription medicines intended to support digestion and nutrient absorption.

Caris Life Sciences Switzerland Holdings GmbH

Since 2013 · 1–10 empl.

Caris Life Sciences Switzerland Holdings GmbH provides comprehensive molecular profiling, protein analysis and AI-based interpretation to deliver therapy-relevant information for patients, physicians and biopharma partners. Its offerings include tissue- and blood-based tests (for example MI Profile and Caris Assure), molecular tumor board services, and multimodal molecular and clinical data and analysis tools for research and clinical development.

LYO-X AG

Since 2014 · 1–10 empl.

The core activity of LYO-X AG is modeling and simulation as well as systems pharmacology for the preclinical and clinical development of biotherapeutics.

NOUSCOM AG

Since 2015 · 21–50 empl.

The core activity of Nouscom is the development of cancer vaccines, in particular neoantigen-based cancer vaccines for tumors with microsatellite instability.

psHolix AG

Since 2015 · 1–10 empl.

psHolix AG develops and markets patented pseudo-holographic display technology for glasses-free 3D viewing. It enables multiple viewers to see spatial content and 2D content simultaneously on the same display, with applications including automotive, aviation, gaming and medical technology.

propatient Forschungsstiftung Universitätsspital Basel

Since 2015 · 11–20 empl.

propatient Forschungsstiftung Universitätsspital Basel funds and supports medical research and innovation projects at Universitätsspital Basel. It focuses particularly on interdisciplinary projects with direct benefits for patients.

IntiQuan AG

Since 2015 · 11–20 empl.

The core activity of IntiQuan AG is the provision of services in the field of pharmacometrics and strategic consulting for the pharmaceutical industry. The company offers Model-informed Drug Development (MIDD) solutions that enable the support of drug development through the application of modeling and simulation methods. The services include, among other things, the performance of pharmacokinetic and pharmacodynamic modeling, the analysis of clinical data, and the development of strategies for the market launch of drugs.

TargImmune Therapeutics AG

Since 2016 · 1–10 empl.

TargImmune Therapeutics AG develops a targeted nucleic acid delivery platform and cancer therapeutics based on it. The approach uses synthetic nanoparticles, and its development programme includes the TAIM compounds TAR001, TAR002 and TAR003.

International Foundation for Patient Blood Management (IFPBM)

Since 2016 · 21–50 empl.

The company's core activity is medical research and education in the field of surgery, particularly in the areas of visceral surgery, vascular surgery, and patient blood management. The company also offers training programs and courses for physicians and surgeons and is involved in the development of educational materials and methods.

epibreed AG

Since 2016 · 1–10 empl.

epibreed AG provides crop-breeding and epigenetics services and has developed the patented TEgenesis® method, which mobilizes transposable elements in seedlings or clones to accelerate natural adaptation processes. Services listed on the website include rapid breeding for abiotic and biotic stress tolerance, increasing phenotypic diversity, generation of inducible traits, gene discovery, and genome-wide DNA methylation analysis.

Nursing Science & Care GmbH

Since 2016 · 11–20 empl.

The core activity of Nursing Science & Care GmbH is the conduct of research, training and consulting in the field of nursing science, particularly in the area of ambulatory care and support for older people. The activities include the creation of scientifically based position papers and expert opinions, the implementation of research projects, the consulting of practice partners and researchers, as well as the training and support of doctoral students in nursing science.

Urovant Sciences GmbH

Since 2016 · 1–10 empl.

Urovant Sciences GmbH is a pharmaceutical company focused on research, development and commercialization of therapies in urology, including treatments for overactive bladder such as Vibegron.

Scailyte AG

Since 2017 · 11–20 empl.

The core activity of Scailyte is the development and application of digital solutions for single-cell analysis, particularly in the field of cell therapy. The company focuses on the development of biomarkers and the application of artificial intelligence and machine learning in single-cell biology. Scailyte provides solutions for the pharmaceutical, biotech, and clinical research industries and develops products such as ScaiVision, a system for single-cell analysis.

Novaremed AG

Since 2017 · 11–20 empl.

Novaremed AG is a clinical-stage biopharmaceutical company developing non-opioid medicines for chronic neuropathic pain. Its pipeline includes nispomeben for painful diabetic peripheral neuropathy and MP-101 for the prevention of chemotherapy-induced peripheral neuropathy.

Immunovant Sciences GmbH

Since 2018 · 11–20 empl.

Immunovant Sciences GmbH is a clinical-stage immunology company developing anti‑FcRn therapies, including IMVT‑1402 and batoclimab, to reduce pathogenic IgG autoantibodies in autoimmune diseases. The product candidates are described as fully human monoclonal antibodies intended for subcutaneous administration with dosing that may be tailored to disease stage and severity.

Prosalix AG

Since 2018 · 1–10 empl.

Prosalix AG is a pharmaceutical company developing Pro24c, a citrate-based medicinal product to treat acid-base imbalances and related risks. Its intended application areas include preventing bladder catheter encrustation and secondary kidney stones.

Synendos Therapeutics AG

Since 2019 · 21–50 empl.

Synendos Therapeutics AG develops drug candidates for neuropsychiatric disorders by targeting the endocannabinoid system. Its focus includes anxiety-, mood- and stress-related conditions, and its lead candidate, SYT-510, is being developed for generalized anxiety disorder.

Laevoroc Medical AG

Since 2019 · 21–50 empl.

VectivBio AG

Since 2019 · 1–10 empl.

VectivBio AG is a company active in gastrointestinal health. It focuses on the development of therapies and medicines for digestive diseases, with activities centered on research, development, and a related product pipeline.

AlphaMeld GmbH

Since 2019 · 11–20 empl.

AlphaMeld GmbH provides AI-driven platforms and services to support drug discovery and development. The AlphaMeld platform integrates biological, chemical and clinical data for target identification, indication optimization, drug design, mechanism-of-action analysis, biomarker discovery and clinical-trial strategy and study design, and includes a generative assistant (ChatAlphaMeld) for user interaction.

SOTIO Biotech AG

Since 2019 · 101–500 empl.

SOTIO Biotech AG is a biopharmaceutical company developing targeted cancer therapies. Its pipeline includes antibody-drug conjugates and an IL-15 immunocytokine candidate, and its activities encompass research and preclinical and clinical development.